<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Arq Bras Cardiol</journal-id><journal-id journal-id-type="iso-abbrev">Arq. Bras. Cardiol</journal-id><journal-id journal-id-type="publisher-id">abc</journal-id><journal-title-group><journal-title>Arquivos Brasileiros de Cardiologia</journal-title></journal-title-group><issn pub-type="ppub">0066-782X</issn><issn pub-type="epub">1678-4170</issn><publisher><publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7020867</article-id><article-id pub-id-type="pmid">31553384</article-id><article-id pub-id-type="doi">10.5935/abc.20190187</article-id><article-categories><subj-group subj-group-type="heading"><subject>Case Report</subject></subj-group></article-categories><title-group><article-title>Myocarditis Following Recent Chikungunya and Dengue Virus Coinfection: A Case Report</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-8978-9903</contrib-id><name><surname>Farias</surname><given-names>Lu&#x000ed;s Arthur Brasil Gadelha</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/></contrib><contrib contrib-type="author"><name><surname>Beserra</surname><given-names>Francisca Lillyan Christyan Nunes</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Fernandes</surname><given-names>Lucas</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Teixeira</surname><given-names>Anderson Alesxander Rodrigues</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ferragut</surname><given-names>Juliana Mandato</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Gir&#x000e3;o</surname><given-names>Evelyne Santana</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Pires Neto</surname><given-names>Roberto da Justa</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref></contrib></contrib-group><aff id="aff1">
<label>1</label> Universidade Federal do Cear&#x000e1; (UFC) - Faculdade de Medicina, Fortaleza, CE - Brazil</aff><aff id="aff2">
<label>2</label> Hospital S&#x000e3;o Carlos - Terapia Intensiva, Fortaleza, CE - Brazil</aff><aff id="aff3">
<label>3</label> Hospital S&#x000e3;o Jos&#x000e9; de Doen&#x000e7;as Infecciosas, Fortaleza, CE - Brazil</aff><aff id="aff4">
<label>4</label> Faculdade de Medicina da Universidade Federal do Cear&#x000e1; - Departamento de Sa&#x000fa;de Comunit&#x000e1;ria, Fortaleza, CE - Brazil</aff><author-notes><corresp id="c1"><bold>Mailing Address: Lu&#x000ed;s Arthur Brasil Gadelha Farias,</bold> Universidade Federal do Cear&#x000e1; (UFC) - Faculdade de Medicina - Rua Juazeiro do Norte, Postal Code 60165-110, Meireles, Fortaleza, CE - Brazil. E-mail: <email>luisarthurbrasilk@hotmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><month>10</month><year>2019</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><month>10</month><year>2019</year></pub-date><volume>113</volume><issue>4</issue><fpage>783</fpage><lpage>786</lpage><history><date date-type="received"><day>30</day><month>6</month><year>2018</year></date><date date-type="rev-recd"><day>06</day><month>10</month><year>2018</year></date><date date-type="accepted"><day>17</day><month>10</month><year>2018</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><kwd-group><kwd>Myocarditis</kwd><kwd>Coinfection</kwd><kwd>Dengue</kwd><kwd>Chikungunya Virus</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Dengue virus (DENV) and chikungunya virus (CHIKV) are arboviruses that cause ongoing epidemics in several countries of Latin America. DENV belongs to the <italic>Flaviviridae</italic> family and CHIKV is an alphavirus of the <italic>Togaviridae</italic> family. Both viruses are transmitted by mosquitoes of the genus <italic>Aedes</italic> (mainly <italic>Aedes aegypti</italic> and <italic>Aedes albopictus</italic>) and during the acute phase they may cause similar nonspecific febrile syndromes that can progress to severe or debilitating conditions.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref></sup></p><p>DENV infection has been endemic in Brazil since the 1980's. However, CHIKV is an emergent agent. Autochthonous transmission was first detected in September 2014 in the city of Oiapoque, Amap&#x000e1; state. Since then, there have been thousands of autochthonous cases in the country.<sup><xref rid="r3" ref-type="bibr">3</xref></sup> A total of 38,499 and 277,882 cases of suspected CHIKV infection were reported by the national surveillance system in 2015 and 2016, respectively. In 2017, a total of 185,369 suspected cases were reported until December 9. Cear&#x000e1; (1,271 cases/100,000 inhabitants) and Roraima (789 cases/100,000 inhabitants) have the highest incidence among the Brazilian Federation states.<sup><xref rid="r4" ref-type="bibr">4</xref></sup> Coinfections with these two viruses have been reported and the overall effect on the heart is still unknown.<sup><xref rid="r5" ref-type="bibr">5</xref>-<xref rid="r7" ref-type="bibr">7</xref></sup> There have been some reports of myopericarditis following DENV and CHIKV infection, but this manifestation in coinfected patients is rare and few data are available.<sup><xref rid="r8" ref-type="bibr">8</xref>-<xref rid="r10" ref-type="bibr">10</xref></sup></p><p>The aim of this report is to present a case of a young and immunocompetent man with myocarditis, following a recent DENV and CHIKV coinfection. We discuss the clinical course and laboratory abnormalities of this rare condition, along with its successful management in an infectious disease specialized center, highlighting the importance of being aware of this condition in developing countries endemic for DENV and CHIKV.</p></sec><sec sec-type="cases"><title>Case report</title><p>The patient was a 28-year-old male, resident in Fortaleza, Cear&#x000e1; State and was admitted in the emergency room of S&#x000e3;o Jos&#x000e9; Hospital of Infectious Diseases in May 2017. The symptoms had started 5 days prior to admission with fever, adynamia, myalgia, and worsening of general condition. He denied retroorbital pain, bleeding phenomena or abdominal pain. He had taken no medications in the previous year and had not traveled outside of Brazil. There was no previous history of cardiopathies.</p><p>Upon the initial examination, the Glasgow Coma Scale (GCS) score of the patient was E4 V5 M6. He had a heart rate of 120 beats per minute and had hypotension (70/40 mm of Hg). There was no heart murmur or pericardial rub and his pulmonary examination was unremarkable. The skin showed no rashes, and there were no petechiae or jaundice.</p><p>The electrocardiogram (EKG) showed supraventricular tachycardia (230 bpm) not responsive to intravenous adenosine. An electric cardioversion was performed and successfully restored the normal heart rhythm. A new EKG was performed showing ST elevation with upper concavity and PR segment depression in DII, DIII and aVF, such as ST depression in V1 and aVR. The patient was then admitted to the intensive care unit. His laboratory parameters are described in <xref rid="t1" ref-type="table">Table 1</xref>. A first transthoracic echocardiogram revealed an altered left ventricular ejection fraction (EF) (43%), left ventricular hypercontractility, and mild bilateral pericardial and pleural effusions (<xref ref-type="fig" rid="f1">Figure 1</xref>). After 5 days, a new echocardiogram was performed, revealing a 36.4% EF, as well as diffuse hypokinesia and moderate pericardial effusion.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Laboratory results during hospital stay of a patient with myocarditis and coinfection with dengue virus and Chikungunya virus</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col width="8%" span="1"/><col width="8%" span="1"/><col width="8%" span="1"/><col width="8%" span="1"/><col width="8%" span="1"/><col width="8%" span="1"/><col width="8%" span="1"/><col width="8%" span="1"/><col width="8%" span="1"/><col width="8%" span="1"/><col width="8%" span="1"/><col width="8%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Characteristic</th><th align="center" rowspan="1" colspan="1">Day 1</th><th align="center" rowspan="1" colspan="1">Day 2</th><th align="center" rowspan="1" colspan="1">Day 3</th><th align="center" rowspan="1" colspan="1">Day 4</th><th align="center" rowspan="1" colspan="1">Day 5</th><th align="center" rowspan="1" colspan="1">Day 6</th><th align="center" rowspan="1" colspan="1">Day 7</th><th align="center" rowspan="1" colspan="1">Day 8</th><th align="center" rowspan="1" colspan="1">Day 9</th><th align="center" rowspan="1" colspan="1">Day 10</th><th align="center" rowspan="1" colspan="1">Day 11</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Hemoglobin, g/dL</td><td align="center" rowspan="1" colspan="1">18.6</td><td align="center" rowspan="1" colspan="1">17.2</td><td align="center" rowspan="1" colspan="1">15.7</td><td align="center" rowspan="1" colspan="1">15.4</td><td align="center" rowspan="1" colspan="1">14.4</td><td align="center" rowspan="1" colspan="1">13.6</td><td align="center" rowspan="1" colspan="1">12.6</td><td align="center" rowspan="1" colspan="1">12.9</td><td align="center" rowspan="1" colspan="1">12.7</td><td align="center" rowspan="1" colspan="1">14.1</td><td align="center" rowspan="1" colspan="1">13.9</td></tr><tr><td align="left" rowspan="1" colspan="1">Hematocrit, %</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">WBC count, x10<sup>3</sup>/mm<sup>3</sup></td><td align="center" rowspan="1" colspan="1">12.5</td><td align="center" rowspan="1" colspan="1">17.4</td><td align="center" rowspan="1" colspan="1">19.6</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">11.1</td><td align="center" rowspan="1" colspan="1">9.4</td><td align="center" rowspan="1" colspan="1">8.1</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">6.1</td><td align="center" rowspan="1" colspan="1">6.7</td></tr><tr><td align="left" rowspan="1" colspan="1">Polymorphs, %</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Lymphocytes, %</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Lymphocyte count, x10<sup>9</sup>/L</td><td align="center" rowspan="1" colspan="1">1.5</td><td align="center" rowspan="1" colspan="1">1.57</td><td align="center" rowspan="1" colspan="1">1.76</td><td align="center" rowspan="1" colspan="1">1.26</td><td align="center" rowspan="1" colspan="1">1.4</td><td align="center" rowspan="1" colspan="1">1.78</td><td align="center" rowspan="1" colspan="1">1.22</td><td align="center" rowspan="1" colspan="1">1.37</td><td align="center" rowspan="1" colspan="1">1.45</td><td align="center" rowspan="1" colspan="1">1.83</td><td align="center" rowspan="1" colspan="1">2.29</td></tr><tr><td align="left" rowspan="1" colspan="1">Platelet count, x10<sup>9</sup>/l</td><td align="center" rowspan="1" colspan="1">135</td><td align="center" rowspan="1" colspan="1">122</td><td align="center" rowspan="1" colspan="1">158</td><td align="center" rowspan="1" colspan="1">177</td><td align="center" rowspan="1" colspan="1">182</td><td align="center" rowspan="1" colspan="1">169</td><td align="center" rowspan="1" colspan="1">160</td><td align="center" rowspan="1" colspan="1">156</td><td align="center" rowspan="1" colspan="1">164</td><td align="center" rowspan="1" colspan="1">199</td><td align="center" rowspan="1" colspan="1">207</td></tr><tr><td align="left" rowspan="1" colspan="1">Creatinine level, mg/dL</td><td align="center" rowspan="1" colspan="1">1.51</td><td align="center" rowspan="1" colspan="1">1.65</td><td align="center" rowspan="1" colspan="1">1.52</td><td align="center" rowspan="1" colspan="1">1.69</td><td align="center" rowspan="1" colspan="1">1.42</td><td align="center" rowspan="1" colspan="1">1.32</td><td align="center" rowspan="1" colspan="1">1.23</td><td align="center" rowspan="1" colspan="1">1.29</td><td align="center" rowspan="1" colspan="1">1.04</td><td align="center" rowspan="1" colspan="1">1.02</td><td align="center" rowspan="1" colspan="1">1.23</td></tr><tr><td align="left" rowspan="1" colspan="1">CRP levels, mg/dl</td><td align="center" rowspan="1" colspan="1">0.89</td><td align="center" rowspan="1" colspan="1">0.99</td><td align="center" rowspan="1" colspan="1">0.45</td><td align="center" rowspan="1" colspan="1">0.35</td><td align="center" rowspan="1" colspan="1">0.25</td><td align="center" rowspan="1" colspan="1">0.43</td><td align="center" rowspan="1" colspan="1">0.53</td><td align="center" rowspan="1" colspan="1">0.52</td><td align="center" rowspan="1" colspan="1">0.31</td><td align="center" rowspan="1" colspan="1">0.21</td><td align="center" rowspan="1" colspan="1">0.14</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum Lactate level mmol/l</td><td align="center" rowspan="1" colspan="1">11.4</td><td align="center" rowspan="1" colspan="1">4.5</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">2.4</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">NT-proBNP, pg/mL</td><td align="center" rowspan="1" colspan="1">32692</td><td align="center" rowspan="1" colspan="1">20858</td><td align="center" rowspan="1" colspan="1">14543</td><td align="center" rowspan="1" colspan="1">13832</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">LDH, IU/L</td><td align="center" rowspan="1" colspan="1">522</td><td align="center" rowspan="1" colspan="1">1371</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">360</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">ESR, mm</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">CK level, U/L</td><td align="center" rowspan="1" colspan="1">1306</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">347</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Troponin I, ng/mL</td><td align="center" rowspan="1" colspan="1">1.05</td><td align="center" rowspan="1" colspan="1">0.5</td><td align="center" rowspan="1" colspan="1">0.47</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">INR</td><td align="center" rowspan="1" colspan="1">1.56</td><td align="center" rowspan="1" colspan="1">1.73</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">1.51</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">1.26</td><td align="center" rowspan="1" colspan="1">1.19</td><td align="center" rowspan="1" colspan="1">1.14</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">1.12</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>WBC: White Blood Cell; CRP: C - Reactive Protein; NT-proBNP: N-Terminal Pro-Brain Natriuretic Peptide; LDH: Lactate Dehydrogenase; ESR: Erythrocyte Sedimentation Rate; CK level: Creatine Kinase level; INR: International Normalized Ratio.</p></fn></table-wrap-foot></table-wrap><p>
<fig id="f1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Transthoracic echocardiogram with altered left ventricular ejection fraction (36.39%), left ventricular hypercontractility, and mild bilateral pericardial effusion (A-D). E-H shows a second transthoracic echocardiogram with ejection fraction of 70%. DP and LP: pericardial effusion. RV: right ventricle; LV: left ventricle; RA: right atrium; LA: left atrium; EF: ejection fraction.</p></caption><graphic xlink:href="abc-113-04-0783-g01"/></fig>
</p><p>Dobutamine (2.9 mcg/Kg/min) IV was initiated and maintained for 4 days and a single dose of 400 mg of hydrocortisone IV was administered. Treatments with immunoglobulin IV or colchicine were not considered. Paired blood cultures were negative for pyogenic agents. Antibiotics were not used.</p><p>Serologies for coxsackie virus, rubella, Chagas disease, human immunodeficiency virus, cytomegalovirus, Epstein-Barr virus (EBV), toxoplasmosis, hepatitis B virus and hepatitis C virus were negative. The patient&#x02019;s serum samples were tested and found to be ELISA-IgM positive and ELISA-IgG positive for DENV and ELISA-IgM positive for CHIKV. The DENV NS1 antigen test yielded a negative result. There was a good response to therapy and the patient progressed with gradual improvement until recovery of ventricular function. After 11 days, a last echocardiogram showed an EF of 70% and persistence of pericardial effusion. The patient was discharged from the hospital 11 days after admission. <xref rid="t1" ref-type="table">Table 1</xref> shows laboratory results during hospital stay.</p></sec><sec sec-type="discussion"><title>Discussion</title><p>Typical clinical manifestations of acute CHIKV infection are fever, headache, polyarthralgia/polyarthritis, myalgia, rash, and fatigue.<sup><xref rid="r11" ref-type="bibr">11</xref></sup> Atypical manifestations have also been described, affecting the cardiovascular, nervous, ocular, cutaneous, and other systems.<sup><xref rid="r6" ref-type="bibr">6</xref>,<xref rid="r12" ref-type="bibr">12</xref>-<xref rid="r14" ref-type="bibr">14</xref></sup> The clinical spectrum of chikungunya heart disease ranges from asymptomatic ECG alterations to potentially lethal cardiac complications.<sup><xref rid="r6" ref-type="bibr">6</xref></sup></p><p>The manifestations of acute DENV infection are very similar to those of CHIKV, with a lower prevalence for joint manifestations.<sup><xref rid="r15" ref-type="bibr">15</xref></sup> Heart involvement in DENV infection is not uncommon. Cardiac manifestations can vary widely, from silent disease to severe myocarditis resulting in death.<sup><xref rid="r7" ref-type="bibr">7</xref></sup> Arora et al.<sup><xref rid="r7" ref-type="bibr">7</xref></sup> studying 120 patients with DENV found 37.5% of patients with cardiac manifestation in the form of myocarditis and 5% with rhythm disturbance, with AV block being the most common.<sup><xref rid="r16" ref-type="bibr">16</xref></sup></p><p>The specific viral diagnosis is commonly made through ELISA, a specific serological test.<sup><xref rid="r11" ref-type="bibr">11</xref>,<xref rid="r15" ref-type="bibr">15</xref></sup> In cases of DENV, secretion of the NS1 non-structural viral protein from infected cells makes an early diagnosis possible. NS1 protein can be detected in blood and tissue samples within 9 days of the onset of fever.<sup><xref rid="r15" ref-type="bibr">15</xref></sup></p><p>There is a low probability that the patient had an isolated viral infection since both viruses are part of different viral families, thus considerably reducing the cross-reaction probability. Kam et al.<sup><xref rid="r17" ref-type="bibr">17</xref></sup> found that 6% of DENV-infected patients had antibodies that were cross-reactive to CHIKV.<sup><xref rid="r17" ref-type="bibr">17</xref></sup> Although they share the same vector, CHIKV is part of the <italic>Togaviridae</italic> family, while DENV is part of the <italic>Flaviviridae</italic> family.</p><p>Heart disease associated with arboviruses has no specific treatment and may be a self-limited condition. Thus, quick supportive therapy to prevent further cardiac function loss and cardiogenic shock is still the most recommended management.<sup><xref rid="r6" ref-type="bibr">6</xref></sup> There is also evidence that IV hydrocortisone may be helpful to accomplish full recovery in DENV myocarditis<sup><xref rid="r18" ref-type="bibr">18</xref></sup> but there is yet no consensus about whether this drug should be used in this setting or if it has a real impact on recovery and mortality rates, even more in cases of combined arbovirus infection. Although arbovirus myocarditis is an acute condition, most patients persist chronically with cardiac disease, such as chronic heart failure and ECG T-wave changes.<sup><xref rid="r16" ref-type="bibr">16</xref>,<xref rid="r19" ref-type="bibr">19</xref></sup> The role of coinfection in the severity of arbovirus cardiac manifestations is not currently known, but studies regarding other symptoms showed that it might contribute to a more severe disease.<sup><xref rid="r6" ref-type="bibr">6</xref>,<xref rid="r7" ref-type="bibr">7</xref>,<xref rid="r20" ref-type="bibr">20</xref></sup> It is also noteworthy that the herein described myocarditis may have been caused solely by the CHIKV, since the NS1 protein test yielded a negative result. It is also important to note that the DENV IgM may be positive from 139 up to 179 days, respectively for secondary and primary infections.<sup><xref rid="r21" ref-type="bibr">21</xref></sup></p><p>The present study has limitations. Polymerase chain reaction (PCR) was not available for the etiological diagnosis. The degree of myocardial impairment was not assessed by Magnetic Resonance Imaging (MRI). Although reported by other authors,<sup><xref rid="r8" ref-type="bibr">8</xref>,<xref rid="r9" ref-type="bibr">9</xref></sup> MRI was not available at our center.</p></sec><sec sec-type="conclusions"><title>Conclusion</title><p>The case presented herein suggests that DENV and CHIKV coinfection may result in myocarditis, which can be severe and may be possibly reverted with supportive therapy and correct management of cardiac function. Nevertheless, the correct etiopathogenesis of the cardiac disorder is undefined and the disease may be caused solely by either the DENV or CHIKV virus. It is important to be aware of this possible complication of arboviruses mainly in endemic areas.</p></sec></body><back><fn-group><fn fn-type="financial-disclosure"><p><bold>Sources of Funding</bold></p><p>There were no external funding sources for this study.</p></fn><fn fn-type="other"><p><bold>Study Association</bold></p><p>This study is not associated with any thesis or dissertation work.</p></fn><fn fn-type="other"><p><bold>Ethics approval and consent to participate</bold></p><p>This study was approved by the Ethics Committee of the Hospital de S&#x000e3;o Jos&#x000e9; de Doen&#x000e7;as Infecciosas under the protocol number 2.405.527. All the procedures in this study were in accordance with the 1975 Helsinki Declaration, updated in 2013.</p></fn><fn fn-type="con"><p><bold>Author contributions</bold></p><p>Conception and design of the research: Farias LABG, Beserra FLCN, Fernandes L, Teixeira AAR, Gir&#x000e3;o ES, Pires Neto RJ; Acquisition of data: Farias LABG, Beserra FLCN, Fernandes L, Teixeira AAR, Ferragut JM, Pires Neto RJ; Analysis and interpretation of the data: Ferragut JM, Gir&#x000e3;o ES, Pires Neto RJ; Statistical analysis: Pires Neto RJ; Writing of the manuscript: Farias LABG, Beserra FLCN, Fernandes L, Teixeira AAR, Pires Neto RJ; Critical revision of the manuscript for intellectual content: Ferragut JM, Gir&#x000e3;o ES, Pires Neto RJ.</p></fn><fn fn-type="COI-statement"><p><bold>Potential Conflict of Interest</bold></p><p>No potential conflict of interest relevant to this article was reported.</p></fn></fn-group><ref-list><title>References</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname><given-names>SV</given-names></name><name><surname>Tesh</surname><given-names>RB</given-names></name><name><surname>Vasilakis</surname><given-names>N</given-names></name></person-group><article-title>The emergence of arthropod-borne viral diseases: A global prospective on dengue, chikungunya and zika fevers</article-title><source>Acta Tropica</source><month>2</month><year>2017</year><volume>166</volume><fpage>155</fpage><lpage>163</lpage><pub-id pub-id-type="pmid">27876643</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Pierson</surname><given-names>TC</given-names></name><name><surname>Diamond</surname><given-names>MS</given-names></name></person-group><chapter-title>Flaviviruses</chapter-title><person-group person-group-type="editor"><name><surname>Knipe</surname><given-names>DM</given-names></name><name><surname>Howley</surname><given-names>PM</given-names></name><name><surname>Cohen</surname><given-names>IC</given-names></name></person-group><source>Fields virology</source><year>2014</year><edition>6th ed.</edition><publisher-loc>Philadelphia</publisher-loc><publisher-name>Wolters Kluwer</publisher-name><fpage>746</fpage><lpage>794</lpage></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donalisio</surname><given-names>M</given-names></name><name><surname>Freitas</surname><given-names>A</given-names></name><name><surname>Zuben</surname><given-names>A</given-names></name></person-group><article-title>Arboviruses emerging in Brazil: challenges for clinic and implications for public health</article-title><source>Rev Saude Publica</source><month>4</month><year>2017</year><volume>51</volume><fpage>30</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">28423140</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Brasil</collab><collab>Minist&#x000e9;rio da Sa&#x000fa;de</collab><collab>Secretaria de Vigil&#x000e2;ncia Sanit&#x000e1;ria</collab></person-group><article-title>Monitoramento dos casos de dengue , febre chikungunya e febre pelo v&#x000ed;rus Zika</article-title><source>Boletim Epidemiol&#x000f3;gico</source><year>2017</year><volume>48</volume><issue>44</issue><fpage>1</fpage><lpage>13</lpage></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furuya-Kanamori</surname><given-names>L</given-names></name><name><surname>Liang</surname><given-names>S</given-names></name><name><surname>Milinovich</surname><given-names>G</given-names></name><name><surname>Magalhaes</surname><given-names>RJS</given-names></name><name><surname>Clements</surname><given-names>ACA</given-names></name><name><surname>Hu</surname><given-names>W</given-names></name><etal/></person-group><article-title>Co-distribution and co-infection of chikungunya and dengue viruses</article-title><source>BMC Infectious Diseases</source><month>3</month><year>2016</year><volume>16</volume><fpage>84</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">26936191</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alvarez</surname><given-names>MF</given-names></name><name><surname>Bol&#x000ed;var-Mej&#x000ed;a</surname><given-names>A</given-names></name><name><surname>Rodriguez-Morales</surname><given-names>AJ</given-names></name><name><surname>Ramirez-Vallejo</surname><given-names>E</given-names></name></person-group><article-title>Cardiovascular involvement and manifestations of systemic Chikungunya virus infection: A systematic review</article-title><source>F1000Res</source><year>2017</year><volume>6</volume><fpage>390</fpage><lpage>390</lpage><pub-id pub-id-type="pmid">28503297</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shivanthan</surname><given-names>M</given-names></name><name><surname>Navinan</surname><given-names>M</given-names></name><name><surname>Constantine</surname><given-names>G</given-names></name><name><surname>Rajapakse</surname><given-names>S</given-names></name></person-group><article-title>Cardiac involvement in dengue infection</article-title><source>J Infect Dev Ctries</source><year>2015</year><volume>9</volume><issue>4</issue><fpage>338</fpage><lpage>346</lpage><pub-id pub-id-type="pmid">25881521</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramanathan</surname><given-names>K</given-names></name><name><surname>Teo</surname><given-names>L</given-names></name><name><surname>Raymond</surname><given-names>W</given-names></name><name><surname>MacLaren</surname><given-names>G</given-names></name></person-group><article-title>Dengue Myopericarditis Mimicking Acute Myocardial Infarction</article-title><source>Circulation</source><year>2015</year><volume>131</volume><issue>23</issue><fpage>519</fpage><lpage>522</lpage><pub-id pub-id-type="pmid">25533968</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simon</surname><given-names>F</given-names></name><name><surname>Paule</surname><given-names>P</given-names></name><name><surname>Oliver</surname><given-names>M</given-names></name></person-group><article-title>Chikungunya virus-induced myopericarditis: toward an increase of dilated cardiomyopathy in countries with epidemics?</article-title><source>Am J Trop Med Hyg</source><year>2008</year><volume>78</volume><issue>2</issue><fpage>212</fpage><lpage>213</lpage><pub-id pub-id-type="pmid">18256416</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maiti</surname><given-names>CR</given-names></name><name><surname>Mukherjee</surname><given-names>AK</given-names></name><name><surname>Bose</surname><given-names>B</given-names></name><name><surname>Saha</surname><given-names>GL</given-names></name></person-group><article-title>Myopericarditis following chikungunya virus infection</article-title><source>J Indian Med Assoc</source><year>1978</year><volume>70</volume><issue>11</issue><fpage>256</fpage><lpage>258</lpage><pub-id pub-id-type="pmid">712084</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cunha</surname><given-names>RVD</given-names></name><name><surname>Trinta</surname><given-names>KS</given-names></name></person-group><article-title>Chikungunya virus: clinical aspects and treatment - A Review</article-title><source>Mem Inst Oswaldo Cruz</source><year>2017</year><volume>112</volume><issue>8</issue><fpage>523</fpage><lpage>531</lpage><pub-id pub-id-type="pmid">28767976</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brizzi</surname><given-names>K</given-names></name></person-group><article-title>Neurologic Manifestation of Chikungunya Virus</article-title><source>Curr Infect Dis Rep</source><year>2017</year><volume>19</volume><issue>2</issue><fpage>6</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">28233188</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahendradas</surname><given-names>P</given-names></name><name><surname>Avadhani</surname><given-names>K</given-names></name><name><surname>Shetty</surname><given-names>R</given-names></name></person-group><article-title>Chikungunya and the eye: a review</article-title><source>J Ophthalmic Inflamm Infect</source><year>2013</year><volume>3</volume><issue>1</issue><fpage>35</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">23514031</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bandyopadhyay</surname><given-names>D</given-names></name><name><surname>Ghosh</surname><given-names>SK</given-names></name></person-group><article-title>Mucocutaneous manifestations of Chikungunya fever</article-title><source>Indian J Dermatol</source><year>2010</year><volume>55</volume><issue>1</issue><fpage>64</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">20418982</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simmons</surname><given-names>CP</given-names></name><name><surname>Farrar</surname><given-names>JJ</given-names></name><name><surname>Nguyen</surname><given-names>VV</given-names></name><name><surname>Wills</surname><given-names>B</given-names></name></person-group><article-title>Dengue</article-title><source>N Engl J Med</source><year>2012</year><volume>366</volume><issue>15</issue><fpage>1423</fpage><lpage>1432</lpage><pub-id pub-id-type="pmid">22494122</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arora</surname><given-names>M</given-names></name><name><surname>Patil</surname><given-names>RS</given-names></name></person-group><article-title>Cardiac Manifestation in Dengue Fever</article-title><source>J Assoc Physicians India</source><year>2016</year><volume>64</volume><issue>7</issue><fpage>40</fpage><lpage>44</lpage></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kam</surname><given-names>YH</given-names></name><name><surname>Pok</surname><given-names>KY</given-names></name><name><surname>Eng</surname><given-names>KE</given-names></name><name><surname>Tan</surname><given-names>LK</given-names></name><name><surname>Kaur</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>WW</given-names></name><etal/></person-group><article-title>Sero-Prevalence and Cross-Reactivity of Chikungunya Virus Specific Anti-E2EP3 Antibodies in Arbovirus-Infected Patients</article-title><source>PLoS Negl Trop Dis</source><year>2015</year><volume>9</volume><issue>1</issue><elocation-id>e3445</elocation-id><pub-id pub-id-type="pmid">25568956</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiwanitkit</surname><given-names>V</given-names></name></person-group><article-title>Dengue myocarditis, rare but not fatal manifestation</article-title><source>Int J Cardiol</source><year>2006</year><volume>112</volume><issue>1</issue><fpage>122</fpage><lpage>122</lpage><pub-id pub-id-type="pmid">16307808</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obeyesekere</surname><given-names>I</given-names></name><name><surname>Hermon</surname><given-names>Y</given-names></name></person-group><article-title>Arbovirus heart disease: myocarditis and cardiomyopathy following dengue and chikungunya fever--a follow-up study</article-title><source>Am Heart J</source><year>1973</year><volume>85</volume><issue>2</issue><fpage>186</fpage><lpage>194</lpage><pub-id pub-id-type="pmid">4688831</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukherjee</surname><given-names>S</given-names></name><name><surname>Dutta</surname><given-names>SK</given-names></name><name><surname>Sengupta</surname><given-names>S</given-names></name><name><surname>Tripathi</surname><given-names>A</given-names></name></person-group><article-title>Evidence of dengue and chikungunya virus co-infection and circulation of multiple dengue serotypes in a recent Indian outbreak</article-title><source>Eur J Clin Microbiol Infect Dis</source><year>2017</year><volume>36</volume><issue>11</issue><fpage>2273</fpage><lpage>2279</lpage><pub-id pub-id-type="pmid">28756561</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prince</surname><given-names>HE</given-names></name><name><surname>Matud</surname><given-names>JL</given-names></name></person-group><article-title>Estimation of Dengue Virus IgM Persistence Using Regression Analysis</article-title><source>Clin Vaccine Immunol</source><year>2011</year><volume>18</volume><issue>12</issue><fpage>2183</fpage><lpage>2185</lpage><pub-id pub-id-type="pmid">22030368</pub-id></element-citation></ref></ref-list></back></article>